PP

Preeti Pandey

Active Director Director DIN 08279796
DIN 08279796 First appointment Nov 2018 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Preeti Pandey

Data last updated:

Preeti Pandey is a Director at Adenocads Pharmaceuticals Private Limited (since 2018). The company operates in Business Services.

DIN 08279796
Primary Designation Director
Industry Business Services
First Appointment 15 Nov 2018
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Nov 20182018Active

Board colleagues of Preeti Pandey

NameDINCompanyDesignation
Vineet Tripathi08279795Adenocads Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Adenocads Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Preeti Pandey

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Preeti Pandey

Preeti Pandey currently holds 1 directorship: Adenocads Pharmaceuticals Private Limited (Director, since 15 Nov 2018).

Preeti Pandey was first appointed on 15 Nov 2018 as Director at Adenocads Pharmaceuticals Private Limited.

The current boards of Preeti Pandey's companies include Vineet Tripathi (Adenocads Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available